ASN Report 2018

T he Marseille division regulates nuclear safety, radiation protection and the transport of nuclear substances in the 6 départements of the Provence‑Alpes‑Côte d’Azur (PACA) region. Provence Alpes- Côte d’Azur region In 2018, ASN carried out 107 inspections in the PACA region, comprising 45 inspections in BNIs, 53 inspections in small- scale nuclear activities, 6 in the transport of radioactive substances and3 concerningorganisations and laboratories approved by ASN. During 2018, three significant events rated level 1 on the INES scale were reported by nuclear installation licensees. In small- scale nuclear activities, 2 significant events rated level 1 on the INES scale were reported to ASN. Five events involving radiotherapy patients were rated level 1 on the ASN-SFRO scale. ASN drew up one violation report in the exercise of its oversight duties. Cadarache site CEA Cadarache centre Created in 1959, the CEA Cadarache centre is situated in the municipality of Saint-Paul-lez-Durance in the Bouches‑du‑Rhône département , and covers a surface area of 1,600 hectares. This site focuses its activity primarily on nuclear energy and, as concerns its civil installations in operation, on research and development to support and optimise the existing reactors and the design of new- generation systems. The following BNIs are located on the site: •  the Pégase‑Cascad installation (BNI 22); •  the Cabri research reactor (BNI 24); •  the Rapsodie research reactor (BNI 25); •  the Solid Waste Treatment Station (STD - BNI 37-A); •  the Effluent Treatment Station (STE, BNI 37-B); REGIONAL OVERVIEWOF NUCLEAR SAFETY AND RADIATION PROTECTION THE INSTALLATIONS AND ACTIVITIES TO REGULATE COMPRISE: ཛྷ ཛྷ BNIs: t ݸݸ he CEA Cadarache research Centre which counts 21 civil BNI’s, including the Jules Horowitz Reactor currently under construction; t ݸݸ he ITER installation construction site, adjacent to the CEA Cadarache centre; t ݸݸ he Gammaster industrial ioniser; ཛྷ ཛྷ small-scale nuclear activities in the medical sector: ݸݸ 12 external-beam radiotherapy departments; ݸݸ 4 brachytherapy departments; ݸݸ 17 nuclear medicine departments; ݸݸ 106 centres performing fluoroscopy-guided interventional procedures; ݸݸ 103 computed tomography scanners; ݸݸ some 8,200 medical and dental radiology devices; ཛྷ ཛྷ small-scale nuclear activities in the veterinary, industrial and research sectors: ݸݸ about 400 industrial and research establishments, including 21 companies exercising an industrial radiography activity; ݸݸ 3 cyclotron particle accelerators; ݸݸ 144 laboratories situated mainly in the universities of the region; ݸݸ about 300 users of devices for detecting lead in paint; ݸݸ about 300 veterinary surgeries or clinics practising diagnostic radiology; ཛྷ ཛྷ activities linked to the transport of radioactive substances; ཛྷ ཛྷ ASN-approved laboratories and organisations: 2 ݸݸ laboratories approved for taking environmental radioactivity measurements; 4 ݸݸ organisations approved for radiation protection controls. see p. 200 see p. 230 see p. 256 80  ASN report on the state of nuclear safety and radiation protection in France in 2018